Use of intracavernosal alprostadil in erectile dysfunction.
作者信息
Gingell C
机构信息
Bristol Urological Institute, Southmead Hospital.
出版信息
Hosp Med. 1998 Oct;59(10):777.
PMID:9850293
Abstract
Alprostadil (prostaglandin E1) is the most widely used, licensed vasoactive agent for intracorporeal injection in the investigation and treatment of erectile dysfunction. It has a good side-effect profile and is effective in between 70 and 80% of patients.
摘要
Zotero 插件